Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

NCT01059539 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

403

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar I Disorder

Interventions

DRUG: Cariprazine

Sponsor

Forest Laboratories

Collaborators

[object Object]